Melatonin can enhancement p53 concentration and decrease micronucleus production rate in albino mice

Marwa Majeed Hameed; Muthana Ibrahim Maleek

doi:10.53730/ijhs.v6nS5.12108

Authors

Marwa Majeed Hameed
majedmarwa023@gmail.com
Department of Biology, College of Science, University of Wasit, Iraq
Muthana Ibrahim Maleek Department of Biology, College of Science, University of Wasit, Iraq

Keywords:

P53, Melatonin, Serum, Micronucleus, Albino Mice

Abstract

Melatonin, as an endogenous hormone, is associated with the moderation of the circadian rhythm. Besides controlling the sleep-wake cycle, many physiological functions of melatonin have been identified, such as antioxidant, immune modulating, and anti-inflammatory. The current study was designed to estimate the effect of different doses of melatonin on gene expression of (p53) in serum and micronucleus (MN) in bone marrow stem cells as cytogenetic test. This investigation was conducted at a Research laboratory in the Department of Biology, College of Science, Wasit University and was designed to evaluate the rate of micronucleus (MN) formation as a cytogenetic test and the level of protein p53 as a serological test. Melatonin (5, 10&15) mg/kg was used for seven consecutive days to know their influence on the parameters before mentioned. Results showed a significantly increased in gene expression (protein) of p53 at P≤0.05 for all three doses of melatonin that were used. While Micronucleus production significant decrease at P≤0.05 for the same doses above of melatonin, when all results above were compared with the control group.

Downloads

Download data is not yet available.

References

Alonso-González, C., González, A., Menéndez-Menéndez, J., Martínez-Campa, C., & Cos, S. (2020). Melatonin as a radio-sensitizer in cancer. Biomedicines, 8(8), 247.‏

Amarneh, B. H., & AL-Dwieb, H. M. (2022). Compassion fatigue, compassion satisfaction, and resilience among intensive care unit nurses. International Journal of Health Sciences, 6(2), 1123–1134. https://doi.org/10.53730/ijhs.v6n2.11415

Andrysik, Z., Galbraith, M. D., Guarnieri, A. L., Zaccara, S., Sullivan, K. D., Pandey, A., ... & Espinosa, J. M. (2017). Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity. Genome research, 27(10), 1645-1657.‏

Ariwibowo, M. F., Wahab, Z., Isnanta, R., & Isnurhadi, I. (2020). Physical evidence promotion on consumer decisions in using bowling sport services. International Journal of Social Sciences and Humanities, 4(3), 22–28. https://doi.org/10.29332/ijssh.v4n3.445

Baumann, K. (2012). Multitasking p53 promotes necrosis. Nature Reviews Molecular Cell Biology, 13(8), 480-481.

Dornan, D., Wertz, I., Shimizu, H., Arnott, D., Frantz, G. D., Dowd, P., & Dixit, V. M. (2004). The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature, 429(6987), 86-92.

Fenech, M. (1993). The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations. Environmental health perspectives, 101(suppl 3), 101-107.

Gnanapradeepan, K., Basu, S., Barnoud, T., Budina-Kolomets, A., Kung, C. P., & Murphy, M. E. (2018). The p53 tumor suppressor in the control of metabolism and ferroptosis. Frontiers in endocrinology, 9, 124.

Green, D. R., & Kroemer, G. (2009). Cytoplasmic functions of the tumour suppressor p53. Nature, 458(7242), 1127-1130.

Ishikawa, H., Tian, Y., & Yamauchi, T. (2000). Induction of micronuclei formation in preimplantation mouse embryos after maternal treatment with 2-bromopropane. Reproductive Toxicology, 15(1), 81-85.‏

Kirsch-Volders, M., Decordier, I., Elhajouji, A., Plas, G., Aardema, M. J., & Fenech, M. (2011). In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models. Mutagenesis, 26(1), 177-184

Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015). p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nature reviews Molecular cell biology, 16(7), 393-405.‏

Li, Y., Li, S., Zhou, Y., Meng, X., Zhang, J. J., Xu, D. P., & Li, H. B. (2017). Melatonin for the prevention and treatment of cancer. Oncotarget, 8(24), 39896

‏Mahal, H. S., Sharma, H. S., & Mukherjee, T. (1999). Antioxidant properties of melatonin: a pulse radiolysis study. Free Radical Biology and Medicine, 26(5-6), 557-565.

Maleek M I, Faraj S A and Alzubaidi D A (2016) Cytogenetic Effects of Ranitidine on Stem Cell L-Asparaginase Treated Mice. Int. J. Sci. & Engineering Investigations 5, 45-51

Qiu, X., Wang, X., Qiu, J., Zhu, Y., Liang, T., Gao, B., ... & Huang, D. (2019). Melatonin rescued reactive oxygen species-impaired osteogenesis of human bone marrow mesenchymal stem cells in the presence of tumor necrosis factor-alpha. Stem cells international, 2019.

Raj, N., & Attardi, L. D. (2017). The transactivation domains of the p53 protein. Cold Spring Harbor perspectives in medicine, 7(1), a026047.‏

‏Reiter, R. J., Tan, D. X., Manchester, L. C., & Tamura, H. (2007). Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. Journal of physiology and pharmacology: an official journal of the Polish Physiological Society, 58, 5-22

‏Russo, A., & Degrassi, F. (2018). Molecular cytogenetics of the micronucleus: Still surprising. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 836, 36-40.

Sandoval‐Herrera, N., Paz Castillo, J., Herrera Montalvo, L. G., & Welch Jr, K. C. (2021). Micronucleus test reveals genotoxic effects in bats associated with agricultural activity. Environmental Toxicology and Chemistry, 40(1), 202-207.‏

Schmid, B. P. (1984). Monitoring of organ formation in rat embryos after in vitro exposure to azathioprine, mercaptopurine, methotrexate or cyclosporin A. Toxicology, 31(1), 9-21.

Shen, C. J., Chang, C. C., Chen, Y. T., Lai, C. S., & Hsu, Y. C. (2016). Melatonin suppresses the growth of ovarian cancer cell lines (OVCAR-429 and PA-1) and potentiates the effect of G1 arrest by targeting CDKs. International journal of molecular sciences, 17(2), 176.

Sumsuzzman, D. M., Khan, Z. A., Choi, J., & Hong, Y. (2021). Differential role of melatonin in healthy brain aging: A systematic review and meta-analysis of the SAMP8 model. Aging (Albany NY), 13(7), 9373.

Sundararajan, S. K., & Natarajan, P. S. (2017). Micronucleus assay in urothelial cells in cancer cervix. Journal of clinical and diagnostic research: JCDR, 11(3), XC01.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949

Tan, D. X., Reiter, R. J., Chen, L. D., Poeggeler, B., Manchester, L. C., & Barlow-Walden, L. R. (1994). Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis, 15(2), 215-218.

Wu, W., Liu, P., & Li, J. (2012). Necroptosis: an emerging form of programmed cell death. Critical reviews in oncology/hematology, 82(3), 249-258.

Zisapel, N. (2018). New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. British journal of pharmacology, 175(16), 3190-3199.